A Single-arm Phase II Study Combining NLG207, a Nanoparticle Camptothecin, with Enzalutamide in Advanced Metastatic Castration-resistant Prostate Cancer Post-Enzalutamide.
Keith T SchmidtFatima KarzaiMarijo BilusicLisa M CordesCindy H ChauCody J PeerSusan WroblewskiAlwin D R HuitemaJan H M SchellensJames L GulleyWilliam L DahutWilliam Douglas FiggRavi A MadanPublished in: The oncologist (2022)
NCT03531827.